INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Aurobindo Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524804	ISIN Demat INE406A01037	Book Value 335.47	NSE Symbol AUROPHARMA	Dividend Yield (%) 0.38	Market Cap (₹ Cr.) 68,669.08	P/E 35.82	EPS 32.72	Face Value 1

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	10,645.64	8,457.00	11,287.14	15,823.68	13,370.77
Sale of Products	10,270.85	8,171.01	11,059.49	15,610.73	13,021.94
Sale of Services	271.36	200.53	190.58	11.45	16.88
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	103.43	85.46	37.07	201.50	331.95
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	10,645.64	8,457.00	11,287.14	15,823.68	13,370.77
Other Income	616.06	443.92	670.99	589.86	388.79
Total Revenue	11,261.70	8,900.92	11,958.13	16,413.54	13,759.56
Changes in Inventories	-116.23	-263.95	45.51	2.99	-238.67
Cost of Material Consumed	5,761.08	4,666.72	5,783.93	7,215.74	6,814.34
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	203.40	89.23	16.81	26.09	5.51
Employee Benefits	980.56	890.53	1,600.04	1,735.42	1,577.14
Total Other Expenses	1,592.79	1,569.56	2,367.45	2,723.61	2,514.58
Manufacturing / Operating Expenses	606.09	496.28	1,183.67	1,438.20	1,340.75
Administrative and Selling Expenses	822.21	939.38	1,009.36	1,069.84	938.36
Other Expenses	164.49	133.90	174.42	215.57	235.47
Finance Costs	182.60	74.58	16.94	28.68	243.28
Depreciation and Amortization	254.58	243.26	415.26	488.00	473.33
Total Expenses	8,858.78	7,269.93	10,245.94	12,220.53	11,389.51
Profit Before Exceptional Items and Tax	2,402.92	1,630.99	1,712.19	4,193.01	2,370.05
Exceptional Items Before Tax	0.00	0.00	-74.71	0.00	0.00
Profit Before Extraordinary Items and Tax	2,402.92	1,630.99	1,637.48	4,193.01	2,370.05
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	2,402.92	1,630.99	1,637.48	4,193.01	2,370.05
Taxation	502.82	388.82	182.77	1,080.10	493.17
Current Tax	598.08	412.16	379.70	1,043.34	492.28
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-95.26	-23.34	-196.93	36.76	0.89
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	1,900.10	1,242.17	1,454.71	3,112.91	1,876.88
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	54.04	-15.06	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	72.49	-19.76	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	-18.45	4.70	0.00	0.00	0.00
Profit Attributable to Shareholders	1,954.14	1,227.11	1,454.71	3,112.91	1,876.88
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	1,954.14	1,227.11	1,454.71	3,112.91	1,876.88
Earning Per Share - Basic	33.35	20.94	24.83	53.13	32.03
Earning Per Share - Diluted	33.35	20.94	24.83	53.13	32.03
Operation Profit before Depreciation	2,840.10	1,948.83	2,144.39	4,709.69	3,086.66
Operating Profit after Depreciation	2,585.52	1,705.57	1,729.13	4,221.69	2,613.33
Dividend Per Share	4.50	7.50	9.00	4.00	3.00
Dividend Percentage	450.00	750.00	900.00	400.00	300.00
Equity Dividend	263.66	439.45	527.34	234.37	175.78
Weighted Average Shares - Basic	58.59	58.59	58.59	58.59	58.59
Weighted Average Shares - Diluted	58.59	58.59	58.59	58.59	58.59